Allergy Therapeutics (LSE: AGY)

Last close As at 05/08/2026

GBP0.05

−0.25 (−4.76%)

Market capitalisation

GBP317m

Allergy Therapeutics is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapies that have the potential to cure disease.

Latest Insights

Healthcare | Quickview

Allergy Therapeutics — H126 results reflect solid progress

Market Data

Share Price GBP0.05
Market Cap GBP317m
52-Week High GBP0.12
52-Week Low GBP0.05
% Change 1M (26.7)
% Change 6M (58.0)
% Change 12M (41.2)
Ave. Daily Volume 1yr 278,211

Sector

Healthcare

Equity Analyst

Key Management

  • Manuel Llobet

    CEO

  • Dr. Shaun Furlong

    CFO

Share Price Chart

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.